You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 139 No. 8, August 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clostridium difficile in Patients With Cystic Fibrosis

Celeste J. Welkon, MD; Sarah S. Long, MD; C. Murry Thompson, Jr, MD; Peter H. Gilligan, PhD

Am J Dis Child. 1985;139(8):805-808.


Abstract

• One hundred seven patients with cystic fibrosis (CF) and 54 other patients with risk factors for Clostridium difficile–associated disease were entered into a bacteriologic study to compare the rate of recovery of C difficile and cytotoxin in feces with occurrence of diarrhea and to investigate potentially protective or permissive relationships of fecal flora. Toxigenic C difficile was recovered from 22% of CF patients and 11% of patients with other diagnoses. Unlike the latter group, the majority (12/15) of CF patients who had cytotoxin recovered had formed stools and no history of diarrhea. Explanations for the lack of symptoms are speculative. Stool flora of CF patients was significantly more likely to include several bacteria with known inhibitory effects on C difficile. Recovery of C difficile and cytotoxin, however, was not associated with the decrease in rate of recovery or the mean bacterial count of any bacterium of fecal flora.

(AJDC 1985;139:805-808)



Author Affiliations

From the Section of Infectious Diseases (Drs Welkon, Long, and Thompson) and Laboratories (Dr Gilligan), St Christopher's Hospital for Children, Philadelphia, and the Departments of Pediatrics (Drs Welkon, Long, Thompson, and Gilligan) and Microbiology and Immunology (Drs Long and Gilligan), Temple University School of Medicine, Philadelphia. Dr Thompson is now in private practice in Mount Pleasant, SC, and Dr Gilligan is now with the Department of Laboratories, North Carolina Memorial Hospital, Chapel Hill.


Footnotes

Reprint requests to Section of Infectious Diseases, St Christopher's Hospital for Children, 2600 N Lawrence St, Philadelphia, PA 19133 (Dr Long).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Case 26-2009 -- A 34-Year-Old Man with Cystic Fibrosis with Abdominal Pain and Distention
Freedman et al.
NEJM 2009;361:807-816.
FULL TEXT  

Abnormal Paneth cell granule dissolution and compromised resistance to bacterial colonization in the intestine of CF mice
Clarke et al.
Am. J. Physiol. Gastrointest. Liver Physiol. 2004;286:G1050-G1058.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.